On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
We are very excited to launch our new website! Please take a few moments to click around and explore...